“…VANGL, a component specific to the PCP, plays a central role in the establishment of the core protein complex (Hatakeyama et al, 2014). Mutations in the VANGLs underlie a broad spectrum of developmental disorders in humans (Butler and Wallingford, 2017), such as neural tube defects (Iliescu et al, 2014;Merello et al, 2015), renal (Papakrivopoulou et al, 2018;Schnell and Carroll, 2016), heart (Yuan et al, 2014;Li and Wang, 2018), and lung diseases (Yates and Dean, 2011). Moreover, recent studies have shown that VANGL2 is consistently upregulated and amplified in breast, ovarian, and uterine carcinomas (Hatakeyama et al, 2014), and a tumorigenic function has been established in rhabdomyosarcoma (Hayes et al, 2018).…”